Scholarlink

Background <p>The congenital disease 2-methylbutyrylglycinuria involves defective isoleucine metabolism and is currently diagnosed based on elevated levels of 2-methylbutyrylcarnitine/isovalerylcarnitine C5 in blood, followed by analysis of 2-methylbutyrylglycine (2-MBG) in urine at an early stage. However, 2-ethylhydracrylic acid (2-EHA) was reported as a more easily detected marker for 2-methylbutyrylglycinuria due to its larger volume in urine. Here we explored the usefulness of two urinary markers for diagnosing the condition.</p> Methods <p>We used electrospray-tandem mass spectrometry to assay levels of C5 and other acylcarnitines in blood and gas chromatography-mass spectrometry to assay levels of 2-MBG and 2-EHA in the urine of 12 individuals diagnosed with 2-methylbutyrylglycinuria based on <i>ACADSB</i> genotyping and in 166 controls. The diagnostic sensitivity and specificity of 2-MBG and 2-EHA were assessed based on receiver operating characteristic curves. Potential associations of levels of the two urinary markers with levels of C5 and other acylcarnitines in blood were explored using Pearson correlation analysis.</p> Results <p>Urine of the 12 individuals with 2-methylbutyrylglycinuria contained a 2-MBG level of 1.78–11.89 (reference range, 0–0) and a 2-EHA level of 37.80-373.13 (reference range, 0-28.69), but levels of both analytes were undetectable or barely detectable in the urine of the 166 controls. Both markers showed 100% diagnostic sensitivity, and 2-MBG showed slightly higher specificity than 2-EHA (2-MBA, 99.5%, 95%CI 0.970-1.00; 2-EHA, 97.8%, 95%CI 0.943–0.994). Levels of 2-MBG, but not 2-EHA, in urine showed a reliable Pearson correlation with levels of C5 in blood (R<sup>2</sup> = 0.71, <i>P</i> = 0.0006), but not with the ratios of C5 to other acylcarnitines in blood.</p> Conclusion <p>The urinary markers 2-MBG and 2-EHA show similar sensitivity for diagnosing 2-methylbutyrylglycinuria, but the lower specificity of 2-EHA and the fact that it can be elevated in several other congenital metabolic disorders means that it should be used as a diagnostic marker only in conjunction with other markers and clinical factors.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Usefulness of levels of 2-methylbutyrylglycine and 2-ethylhydracrylic acid in urine for diagnosing 2-methylbutyrylglycinuria

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月1日

查看全文
  • Hao Liu,
  • Ming Xu,
  • Min Chen,
  • Yong Peng,
  • Liang Ye,
  • Yi-fan Yin,
  • Jing-kun Miao

摘要

Background

The congenital disease 2-methylbutyrylglycinuria involves defective isoleucine metabolism and is currently diagnosed based on elevated levels of 2-methylbutyrylcarnitine/isovalerylcarnitine C5 in blood, followed by analysis of 2-methylbutyrylglycine (2-MBG) in urine at an early stage. However, 2-ethylhydracrylic acid (2-EHA) was reported as a more easily detected marker for 2-methylbutyrylglycinuria due to its larger volume in urine. Here we explored the usefulness of two urinary markers for diagnosing the condition.

Methods

We used electrospray-tandem mass spectrometry to assay levels of C5 and other acylcarnitines in blood and gas chromatography-mass spectrometry to assay levels of 2-MBG and 2-EHA in the urine of 12 individuals diagnosed with 2-methylbutyrylglycinuria based on ACADSB genotyping and in 166 controls. The diagnostic sensitivity and specificity of 2-MBG and 2-EHA were assessed based on receiver operating characteristic curves. Potential associations of levels of the two urinary markers with levels of C5 and other acylcarnitines in blood were explored using Pearson correlation analysis.

Results

Urine of the 12 individuals with 2-methylbutyrylglycinuria contained a 2-MBG level of 1.78–11.89 (reference range, 0–0) and a 2-EHA level of 37.80-373.13 (reference range, 0-28.69), but levels of both analytes were undetectable or barely detectable in the urine of the 166 controls. Both markers showed 100% diagnostic sensitivity, and 2-MBG showed slightly higher specificity than 2-EHA (2-MBA, 99.5%, 95%CI 0.970-1.00; 2-EHA, 97.8%, 95%CI 0.943–0.994). Levels of 2-MBG, but not 2-EHA, in urine showed a reliable Pearson correlation with levels of C5 in blood (R2 = 0.71, P = 0.0006), but not with the ratios of C5 to other acylcarnitines in blood.

Conclusion

The urinary markers 2-MBG and 2-EHA show similar sensitivity for diagnosing 2-methylbutyrylglycinuria, but the lower specificity of 2-EHA and the fact that it can be elevated in several other congenital metabolic disorders means that it should be used as a diagnostic marker only in conjunction with other markers and clinical factors.